Albemarle (ALB) Cash & Equivalents (2009 - 2026)

Albemarle (ALB) has 18 years of Cash & Equivalents data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Cash & Equivalents fell 28.23% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 28.23% YoY) and the FY2025 annual result came in at $1.6 billion, up 35.71% from the prior year.
• Cash & Equivalents slipped to $1.1 billion in Q1 2026, from $1.6 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.1 billion in Q1 2024 to a low of $463.3 million in Q1 2022.
• A 5-year average of $1.5 billion and a median of $1.6 billion in 2023 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 242.47% in 2023, down 40.64% in 2023.
• Tracing ALB's Cash & Equivalents over 5 years: stood at $1.5 billion in 2022, then tumbled by 40.64% to $889.9 million in 2023, then soared by 33.97% to $1.2 billion in 2024, then surged by 35.71% to $1.6 billion in 2025, then slumped by 32.64% to $1.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.1 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.